Disease burden, management strategies, and unmet needs in α‐thalassemia due to hemoglobin H disease

Documenti analoghi

• Improving healthspan among people with sickle cell disease: Leveraging precision health in an era of treatments with curative intent
  di: Elaine A. Yu, et al.
  Pubblicazione: (2024)
• ‘Phenoconversion’ in adult patients with β‐thalassemia
  di: Khaled M. Musallam, et al.
  Pubblicazione: (2024)
• Moderate–severe beta‐thalassemia intermedia phenotype caused by sextuplicated alpha‐globin gene allele in two beta‐thalassemia carriers
  di: Ahlem Achour, et al.
  Pubblicazione: (2024)
• Suppression of Hb Bart's to improve tissue oxygenation and fetal development in homozygous alpha‐thalassemia
  di: G. Lugthart, et al.
  Pubblicazione: (2024)
• Real‐world efficacy and safety of luspatercept and predictive factors of response in patients with transfusion‐dependent β‐thalassemia
  di: Daniele Lello Panzieri, et al.
  Pubblicazione: (2024)